In 1982, the FDA approved thermography (also known as Digital Infrared Thermal Imaging) as a supplementary breast cancer screening tool. But over 34 years later, we hear very little about thermography and its benefits. Let’s take a look at why this is . . .
The mammography industry in America is a multi-billion dollar cash cow that has successfully put a lid on breast thermography and its proven benefits. For the last 30+ years, the mammography industry has successfully carried out a campaign to conceal lifesaving thermography technology, at the detriment of American women.
The simple fact is that the astonishing precision of breast thermography is scientifically proven, while the overwhelming disadvantages and failures of mammography screening has been published. Then why is it that breast thermography is relegated to a corner while mammography screening is encouraged? The answer is MONEY!
The mammography screening financial empire has the ability to generate over $6 billion in revenue, if American women followed the recommendations by the American Cancer Society to undergo regular mammography tests.
If you are still unconvinced about the pronouncements given above, here is expert testimony published in top medical journals:
“There is little evidence documenting that mammography saves lives from breast cancer for premenopausal women.”
– AMA journal 2003 issue, American Medical News
“Screening for breast cancer with mammography is unjustified…the data show that for every 1000 women screened biennially throughout 12 years, one breast-cancer death is avoided whereas the total number of deaths is increased by six…there is no reliable evidence that screening decreases breast-cancer mortality.”
– The Lancet, 2000 Issue
As you can see, highly regarded medical professionals have stated in numerous prestigious medical journals that the use of mammography screening for early breast cancer detection is both ineffective and inaccurate. The medical professionals say it and the studies prove it: mammography screening has very few benefits, and the health hazards to women far exceed them.
Furthermore, since the introduction of mammography screening over 45 years ago, the occurrence of Ductal Carcinoma in Situ (DCIS) has risen by 328%, 200% of which has been attributed to mammography screening.
Even with all of this information, mammography is still recommended and promoted by physicians and medical institutions, while thermography is rarely talked about.
It’s time we started having honest conversations about breast screening options.
